SYRE
USDSpyre Therapeutics Inc. Common Stock
Reaalajas hind
Hinnagraafik
Põhinäitajad
Turunäitajad
Avatud
$21.880
Kõrge
$22.540
Madal
$21.150
Maht
0.80M
Ettevõtte fundamentaalnäitajad
Turukapitalisatsioon
1.7B
Tööstusharu
Biotehnoloogia
Riik
United States
Kauplemisstatistika
Keskmine maht
0.83M
Börs
NMS
Valuuta
USD
52 nädala vahemik
Seotud uudised
Spyre Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Reported positive interim Phase 1 results for SPY003, a next-generation anti-IL-23 antibody, demonstrating the molecule was well-tolerated and exhibited an ~85-day half-life supporting quarterly or twice annual
Spyre Therapeutics to Participate in Upcoming November Investor Conferences
WALTHAM, Mass., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Spyre Therapeutics, Inc. (NASDAQ:SYRE), a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of
Spyre Therapeutics Announces Poster Presentations at American College of Rheumatology (ACR) Convergence 2025
WALTHAM, Mass., Oct. 24, 2025 (GLOBE NEWSWIRE) -- Spyre Therapeutics, Inc. (NASDAQ:SYRE), a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of
Seotud aktsiad
CDXC
ChromaDex Corporation
NNI
Nelnet Inc.
KTH
Structures Products Cp 8% CorTS Issued by Peco Energy Cap Tr II Preferred Stock
XFLT
XAI Octagon Floating Rate & Alternative Income Trust Common Shares of Beneficial Interest
LTRYW
Lottery.com Inc. Warrants
Püsi kursis
Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.